Addressing Genomic Disparities in Cancer Survivors

Recruiting N/A Interventional Study
Hereditary Cancer Genetic Testing
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
428 (estimated)
Sponsor
Rutgers, The State University of New Jersey · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to increase genetic education and genetic testing for hereditary cancer risk among Black cancer survivors. The study will: 1. Test the effectiveness of a chatbot intervention (also called relational agent, or RA) vs. enhanced usual care (EUC) on engagement in genetic education and requests for genetic testing. 2. Evaluate the impact of the chatbot vs. EUC o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18-80 years of age * Self-identify as Black or African American * At least 6-months post diagnosis with any of the following cancers: breast, ovarian, uterine, prostate, colorectal, pancreatic * Have not had genetic testing for hereditary cancer * Have received care at one of …
Contacts

Erin Speiser, PhD, MA

732-675-1668

erin.speiser@rutgers.edu

CONTACT

Julie Chapman Greene, PhD, MPH

chapmaje@cinj.rutgers.edu

CONTACT